How Is EZZ’s US Market Strategy Shaping Up Amid Q1 Sales Dip?

middle.news 7:01pm on Thursday 30th of October, 2025 AEDT • Life Sciences Read Story

How Is EZZ’s US Market Strategy Shaping Up Amid Q1 Sales Dip?

7:01pm on Thursday 30th of October, 2025 AEDT Key Points Q1 FY26 receipts down 25.4% to $11.5 million Shift to performance-based digital marketing in US, targeting TikTok and Amazon Three new products launched, Breast Health, Women’s Bone Strength, and R-21 Ergothioneine capsules Expanded Australian pharmacy network with new wholesalers and stores Read Story

middle. Tap to Read Tap the card to read the full analysis about Ezz Life Science Holdings (ASX:EZZ) OPEN ARTICLE